These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21467110)

  • 21. Concerns, expectations and perception regarding stature, physical appearance and psychosocial functioning before and during high-dose growth hormone treatment of short pre-pubertal children born small for gestational age.
    Lagrou K; Froidecoeur C; Thomas M; Massa G; Beckers D; Craen M; de Beaufort C; Rooman R; François I; Heinrichs C; Lebrethon MC; Thiry-Counson G; Maes M; De Schepper J
    Horm Res; 2008; 69(6):334-42. PubMed ID: 18504392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of catch-up growth from orthodontic treatment and supplemental growth hormone therapy by using Z-scores.
    Tsuboi Y; Yamashiro T; Ando R; Takano-Yamamoto T
    Am J Orthod Dentofacial Orthop; 2008 Mar; 133(3):450-8. PubMed ID: 18331947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
    Moore WV; Dana K; Frane J; Lippe B
    Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which children with idiopathic short stature should receive growth hormone therapy?
    Czernichow P
    Nat Clin Pract Endocrinol Metab; 2008 Mar; 4(3):118-9. PubMed ID: 18040291
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
    Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
    Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Response to Growth Hormone Treatment in a Patient with Insulin-Like Growth Factor 1 Receptor Deletion.
    Mahmoud R; Naidu A; Risheg H; Kimonis V
    J Clin Res Pediatr Endocrinol; 2017 Dec; 9(4):380-386. PubMed ID: 28720553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth hormone use in the treatment of idiopathic short stature.
    Zucchini S
    Curr Opin Investig Drugs; 2008 Apr; 9(4):396-401. PubMed ID: 18393106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Idiopathic short stature: management and growth hormone treatment.
    Wit JM; Reiter EO; Ross JL; Saenger PH; Savage MO; Rogol AD; Cohen P
    Growth Horm IGF Res; 2008 Apr; 18(2):111-35. PubMed ID: 18178498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The molecular basis of idiopathic short stature.
    Rosenfeld RG
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S3-5. PubMed ID: 16023877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth hormone therapy.
    Dash RJ; Muralidharan R; Talwar V
    J Assoc Physicians India; 1999 Apr; 47(4):417-25. PubMed ID: 10778529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone: the expansion of available products and indications.
    Franklin SL; Geffner ME
    Pediatr Clin North Am; 2011 Oct; 58(5):1141-65, x. PubMed ID: 21981953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Approach to short stature.
    Yadav S; Dabas A
    Indian J Pediatr; 2015 May; 82(5):462-70. PubMed ID: 25465677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone treatment for childhood short stature and risk of stroke in early adulthood; adult stroke risk after growth hormone treatment in childhood: first do no harm.
    Stagnaro S
    Neurology; 2015 Apr; 84(15):1613-4. PubMed ID: 25870454
    [No Abstract]   [Full Text] [Related]  

  • 35. Growth hormone treatment of idiopathic short stature: history and demographic data from the NCGS.
    Kemp SF
    Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S9-12. PubMed ID: 16024264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone treatment 50 years down the line - are we getting value?
    Hindmarsh PC
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):11-2. PubMed ID: 22404703
    [No Abstract]   [Full Text] [Related]  

  • 37. Etiology and patterns of presentation of short stature in Eastern Cape of South Africa.
    Ekpebegh C
    Minerva Endocrinol; 2018 Jun; 43(2):225-227. PubMed ID: 29761686
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth hormone treatment in patients with hypochondroplasia.
    Regelmann MO; Rapaport R
    Horm Res Paediatr; 2014; 82(6):353-4. PubMed ID: 25531227
    [No Abstract]   [Full Text] [Related]  

  • 39. Editorial: Short stature: beyond growth hormone.
    Plachy L; Deodati A; Tornese G
    Front Endocrinol (Lausanne); 2024; 15():1403112. PubMed ID: 38606084
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-Acting Growth Hormone in Idiopathic Short Stature.
    Saenger P; Zamora-Siliezar L
    Horm Res Paediatr; 2018; 90(1):64-65. PubMed ID: 30001531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.